SCHEMBL15324203

SCHEMBL15324203

C=CC(=O)OCCC(C)OC(=O)C(=C)O

nearest known ligand 0.44

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
TSHR P16473 8/20 0.44
HPGD P15428 1/20 0.43
ALDH1A1 P00352 4/20 0.43
TP53 P04637 3/20 0.43
HIF1A Q16665 3/20 0.43
CYP3A4 P08684 2/20 0.43
HSD17B10 Q99714 1/20 0.43
THRB P10828 2/20 0.37
MAPK1 P28482 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31195682 0.85 TSHR (0.48) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL262349 0.84 TSHR (0.52) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL5030657 0.82 TSHR (0.40) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL12266937 0.81 TSHR (0.48) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL15509425 0.81 TSHR (0.53) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL12112392 0.80 TSHR (0.47) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL7866513 0.80 TSHR (0.51) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL15509423 0.79 TSHR (0.58) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL19845005 0.78 TSHR (0.42) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL759108 0.78 TSHR (0.52) TSHRHPGDALDH1A1TP53HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3140337-A1 CURABLE URETHANE (METH)ACRYLATE POLYMER COMPOSITIONS AND METHODS Arkema France (FR) 2017-03-15 EP disclosed
WO-2015169644-A1 CURABLE URETHANE (METH)ACRYLATE POLYMER COMPOSITIONS AND METHODS. ARKEMA FRANCE (FR) 2015-11-12 WO disclosed
WO-2013154845-A1 CURABLE NAIL ENHANCEMENTS ESSCHEM, INC. (US) 2013-10-17 WO disclosed